Konstantinos Nikolaos Syrigos
National and Kapodistrian University of Athens · 323 works · 9,251 citations · h-index 47
Top works
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- Programmed death ligand-1 expression in non-small cell lung cancer
- Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
- Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors
- Thyroid Transcription Factor 1 Is an Independent Prognostic Factor for Patients With Stage I Lung Adenocarcinoma
- E-cadherin/catenin complex in benign and malignant melanocytic lesions
- Circulating VEGF Levels in the Serum of Gastric Cancer Patients
- Management of Malignant Pleural Effusions
- Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.
- E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival
- Lung cancer in never smokers: Disease characteristics and risk factors
- Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
- Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease
- Analytic Variability in Immunohistochemistry Biomarker Studies
- Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis
- High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling
- Influence of tumour size on uptake of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model
- Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
- ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCER
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies